Defects in interferon-receptor signaling and antigen presentation pathways, tumor-associated neoantigen loss, alternate immune checkpoints, and alterations in the tumor microenvironment are believed to be involved in AR mechanisms10–12. Here, IFNAR2 is linked to neoplasm.